• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病及其并发症的诊断与治疗。

Diagnosis and treatment of alcoholic liver disease and its complications.

作者信息

Marsano Luis S, Mendez Christian, Hill Daniell, Barve Shirish, McClain Craig J

机构信息

Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky, USA.

出版信息

Alcohol Res Health. 2003;27(3):247-56.

PMID:15535453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6668876/
Abstract

Alcoholic liver disease (ALD) is a serious and potentially fatal consequence of alcohol use. The diagnosis of ALD is based on drinking history, physical signs and symptoms, and laboratory tests. Treatment strategies for ALD include lifestyle changes to reduce alcohol consumption, cigarette smoking, and obesity; nutrition therapy; and pharmacological therapy. The diagnosis and management of the complications of ALD are important for alleviating the symptoms of the disease, improving quality of life, and decreasing mortality.

摘要

酒精性肝病(ALD)是酒精使用导致的严重且可能致命的后果。ALD的诊断基于饮酒史、体征和症状以及实验室检查。ALD的治疗策略包括改变生活方式以减少酒精摄入、吸烟和肥胖;营养治疗;以及药物治疗。ALD并发症的诊断和管理对于缓解疾病症状、提高生活质量和降低死亡率至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/4e0efdc716c8/247-256f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/38baa57be6a3/247-256f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/3ad86ff4c01b/247-256f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/7e55fcba0903/247-256f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/4e0efdc716c8/247-256f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/38baa57be6a3/247-256f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/3ad86ff4c01b/247-256f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/7e55fcba0903/247-256f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8136/6668876/4e0efdc716c8/247-256f4.jpg

相似文献

1
Diagnosis and treatment of alcoholic liver disease and its complications.酒精性肝病及其并发症的诊断与治疗。
Alcohol Res Health. 2003;27(3):247-56.
2
Decompensated alcohol related liver disease: acute management.失代偿期酒精性肝病:急性处理
BMJ. 2016 Jan 26;352:i124. doi: 10.1136/bmj.i124.
3
Nutrition in alcoholic liver disease.酒精性肝病中的营养
Nutr Clin Pract. 2006 Jun;21(3):245-54. doi: 10.1177/0115426506021003245.
4
Advances in alcoholic liver disease.酒精性肝病的进展
Best Pract Res Clin Gastroenterol. 2003 Aug;17(4):625-47. doi: 10.1016/s1521-6918(03)00053-2.
5
Alcoholic liver disease. Treatment strategies for the potentially reversible stages.酒精性肝病。潜在可逆阶段的治疗策略。
Postgrad Med. 1998 Apr;103(4):261-4, 267-8, 273-5. doi: 10.3810/pgm.1998.04.462.
6
[Established therapies and new therapeutic strategies in alcoholic liver disease].[酒精性肝病的既定疗法与新治疗策略]
Z Gastroenterol. 2017 Mar;55(3):291-303. doi: 10.1055/s-0042-119454. Epub 2016 Dec 6.
7
Alcoholic liver disease: treatment.酒精性肝病:治疗
World J Gastroenterol. 2014 Sep 28;20(36):12934-44. doi: 10.3748/wjg.v20.i36.12934.
8
Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease.营养与酒精性肝病:酗酒对营养的影响、营养对酒精性肝病的影响以及酒精性肝病的营养疗法。
Clin Liver Dis. 2016 Aug;20(3):535-50. doi: 10.1016/j.cld.2016.02.010. Epub 2016 Apr 23.
9
Trends in the management and burden of alcoholic liver disease.酒精性肝病的管理趋势与负担
J Hepatol. 2015 Apr;62(1 Suppl):S38-46. doi: 10.1016/j.jhep.2015.03.006.
10
Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.日本酒精性肝病的现状与治疗策略
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2016 Aug;51(2):71-90.

引用本文的文献

1
Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death.危及生命的风险因素通过诱导程序性坏死性细胞死亡,促成了死亡率最高的疾病的发展。
Cell Death Dis. 2025 Apr 11;16(1):273. doi: 10.1038/s41419-025-07563-7.
2
A Complex Interplay between Nutrition and Alcohol use Disorder: Implications for Breaking the Vicious Cycle.营养与酒精使用障碍之间的复杂相互作用:对打破恶性循环的启示。
Curr Pharm Des. 2024;30(23):1822-1837. doi: 10.2174/0113816128292367240510111746.
3
Lipid and renal profile in assessing the severity of alcoholic liver disease.

本文引用的文献

1
Dietary treatment of cirrhosis of the liver; results in 124 patients observed during a 10 year period.肝硬化的饮食治疗;10年间对124例患者的观察结果
J Am Med Assoc. 1948 Oct 23;138(8):543-9. doi: 10.1001/jama.1948.02900080001001.
2
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.去甲肾上腺素和白蛋白对I型肝肾综合征患者的影响:一项初步研究。
Hepatology. 2002 Aug;36(2):374-80. doi: 10.1053/jhep.2002.34343.
3
Propylthiouracil for alcoholic liver disease.丙硫氧嘧啶用于治疗酒精性肝病。
评估酒精性肝病严重程度时的血脂和肾脏指标
Bioinformation. 2022 Oct 31;18(10):1036-1040. doi: 10.6026/973206300181036. eCollection 2022.
4
Purastat as an Adjunct Treatment Option in Acute Esophageal Varices Bleeding: A Case Report.Purastat作为急性食管静脉曲张出血的辅助治疗选择:一例报告
Cureus. 2023 Jul 30;15(7):e42712. doi: 10.7759/cureus.42712. eCollection 2023 Jul.
5
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database.非酒精性脂肪性肝病、非酒精性脂肪性肝炎和肝硬化进展中的肠道微生物群及其与生物制剂的联系:一项使用Dimensions科学研究数据库的文献计量学研究
Biology (Basel). 2023 Apr 27;12(5):662. doi: 10.3390/biology12050662.
6
Spirulina supplementation improves bone structural strength and stiffness in streptozocin-induced diabetic rats.补充螺旋藻可改善链脲佐菌素诱导的糖尿病大鼠的骨结构强度和硬度。
J Tradit Complement Med. 2021 Aug 3;12(3):225-234. doi: 10.1016/j.jtcme.2021.07.010. eCollection 2022 May.
7
Alcohol use disorder and its determinant factors among patients with schizophrenia attending treatment at mental specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study.埃塞俄比亚亚的斯亚贝巴一家精神专科医院中接受治疗的精神分裂症患者的酒精使用障碍及其决定因素:一项横断面研究。
SAGE Open Med. 2021 Sep 28;9:20503121211048748. doi: 10.1177/20503121211048748. eCollection 2021.
8
Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury.干酪乳杆菌对酒精性肝损伤患者脂代谢及肠道微生态的影响。
Eur J Clin Nutr. 2021 Aug;75(8):1227-1236. doi: 10.1038/s41430-020-00852-8. Epub 2021 Jan 29.
9
The prevalence and factors associated with alcohol use disorder among people living with HIV/AIDS in Africa: a systematic review and meta-analysis.在非洲,艾滋病毒/艾滋病患者中酒精使用障碍的流行情况及其相关因素:系统评价和荟萃分析。
Subst Abuse Treat Prev Policy. 2020 Aug 24;15(1):63. doi: 10.1186/s13011-020-00301-6.
10
Non-invasive assessment of liver fibrosis in alcoholic liver disease.酒精性肝病中肝纤维化的无创评估
Clin Exp Hepatol. 2020 Jun;6(2):125-130. doi: 10.5114/ceh.2020.95739. Epub 2020 May 27.
Cochrane Database Syst Rev. 2002(2):CD002800. doi: 10.1002/14651858.CD002800.
4
Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.秋水仙碱对酒精性肝硬化无效:一项双盲随机试验的最终结果
Eur J Gastroenterol Hepatol. 2002 Apr;14(4):377-81. doi: 10.1097/00042737-200204000-00007.
5
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.皮质类固醇可改善重症酒精性肝炎(AH)患者的短期生存率:对皮质类固醇治疗重症AH的最近三项随机安慰剂对照双盲试验的个体数据分析
J Hepatol. 2002 Apr;36(4):480-7. doi: 10.1016/s0168-8278(01)00289-6.
6
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.特利加压素治疗肝硬化合并1型肝肾综合征患者:一项回顾性多中心研究。
Gastroenterology. 2002 Apr;122(4):923-30. doi: 10.1053/gast.2002.32364.
7
Risk factors of fibrosis in alcohol-induced liver disease.酒精性肝病中纤维化的危险因素。
Hepatology. 2002 Mar;35(3):635-8. doi: 10.1053/jhep.2002.31782.
8
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.慢性丙型肝炎患者的吸烟与肝脏病变
Hepatology. 2001 Jul;34(1):121-5. doi: 10.1053/jhep.2001.25385.
9
Management of ascites.腹水的管理
Clin Liver Dis. 2001 May;5(2):541-68, viii. doi: 10.1016/s1089-3261(05)70177-x.
10
Portal hypertension.门静脉高压症
Clin Liver Dis. 2001 May;5(2):509-40. doi: 10.1016/s1089-3261(05)70176-8.